Allogene Therapeutics, Inc. ($ALLO)
Filing Information
| Accession Number | 0001737287-26-000011 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 4, 2026 |
| Document Date | Feb 2, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
487,026
Total Value
$13,059.77
P&L
+inf% (+$992,517.39)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SVP, Chief Technical Officer | Common Stock | โ | Feb 2, 2026 | Sale | 7,549 | $1.73 | $13,059.77 | 210,172 | Direct | โ | View Details | |
SVP, Chief Technical Officer | Stock Option (Right to buy) | Derivative | Feb 2, 2026 | Grant/Award | 373,757 | $0.00 | $0.00 | 373,757 | Direct | โ | View Details | |
SVP, Chief Technical Officer | Restricted Stock Unit | Derivative | Feb 2, 2026 | Grant/Award | 105,720 | $0.00 | $0.00 | 105,720 | Direct | โ | View Details |